To investigate the relationship between the polymorphism of Uridine diphosphate glucuronosyltransferases (UGT)1A4 142T>G (*3, L48V, rs 2011425)and serum concentration of lamotrigine(LTG) in Chinese epileptic patients. Databases including Cochrane Library, PubMed, Embase, CNKI, VIP and Wanfang were searched for the studies on the relationship of the polymorphisms of UGT1A4 142T>G with concentration of LTG (from the establishment a database to December 1, 2017). Meta-analysis was performed by RevMan 5.3. We pooled data from 6 literatures, including 903 Chinese epileptic patients. Meta-analysis: In terms of the effect of UGT1A4 142T>G polymorphism on the serum concentration/dose ratio(CDR)of LTG, there was no significant difference between the wild-type(TT genotype)group and mutant-type (TG+ GG genotype) group (=-0.08, 95% (-0.40-0.23)). Further subgroup analysis was performed on LTG monotherapy or valproic acid(VPA)co-administration. For patients treated with LTG as monotherapy, difference was not statistically significant between the 2 groups(=0.16, 95% (-0.25-0.57)). But in children treated with VPA co-administration, difference was statistically significant between the 2 groups (=-0.50, 95% (-0.75--0.26)). UGT1A4 142T>G polymorphism has an effect on LTG concentration only with VPA co-administration in Chinese epileptic pediatric patients and those children with wild-type (TT genotype) have a tendency to have a lower serum concentration of lamotrigine.

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.0376-2491.2018.41.015DOI Listing

Publication Analysis

Top Keywords

ugt1a4 142t>g
20
chinese epileptic
16
142t>g polymorphism
12
serum concentration
12
epileptic patients
12
polymorphism serum
8
concentration lamotrigine
8
ltg monotherapy
8
difference statistically
8
vpa co-administration
8

Similar Publications

Article Synopsis
  • The study aimed to assess how genetic variations (polymorphisms) in the UGT1A4 and UGT2B7 genes impact the levels of lamotrigine in the blood of Chinese patients with bipolar disorder.
  • Researchers analyzed data from 104 patients who had been on a consistent dose of lamotrigine for at least 21 days, measuring plasma concentrations using advanced chromatography techniques.
  • Findings revealed that specific genetic profiles (UGT1A4 -142T>G and UGT2B7 -161C>T) significantly influenced lamotrigine levels, with certain genotypes associated with higher concentrations of the drug in the bloodstream.
View Article and Find Full Text PDF

Background: Valproate inhibits clearance of lamotrigine and greatly increases its concentrations. We assessed whether this effect was moderated by a polymorphism (ABCG2 c.421C>A) of the breast cancer resistance protein.

View Article and Find Full Text PDF

Effect of UGT1A4, UGT2B7, UGT2B15, UGT2B17 and ABC1B polymorphisms on lamotrigine metabolism in Danish patients.

Epilepsy Res

May 2022

Department of Laboratory Medicine, Division of Clinical Pharmacology at Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.

Objective: To evaluate the impact of genetic polymorphisms of UGT enzymes (UGT1A4, UGT2B7, UGT2B15 and UGT 2B17) and the transporter protein ABCB1 on Lamotrigine (LTG) metabolism.

Methods: Single nucleotide polymorphisms UGT1A4*2 (P24T, c.70C>A), UGT1A4*3 (L48V c.

View Article and Find Full Text PDF

This study investigated the association between voriconazole-induced liver injury and gene polymorphisms of and . Thirty-eight adult patients who received voriconazole therapy were included in the study. Genotype of was detected using gene chip hybrid analysis.

View Article and Find Full Text PDF

Background: In a previous study, the authors had shown that in treatment-resistant depressive disorder, an early therapeutic response to lamotrigine augmentation therapy is dependent on its plasma concentrations. Lamotrigine is mainly metabolized by UGT1A4 and UGT2B7, and polymorphisms of said UGTs that affect enzyme activities have been reported. This study investigated the effect of these polymorphisms on the steady-state plasma concentrations (Css) of lamotrigine in patients with treatment-resistant depressive disorder receiving lamotrigine as augmentation therapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!